How fakers are taking advantage of the pandemic.

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

A gene therapy could help prevent the symptoms of glaucoma.

Robert Dudley reveals his lessons learned and shares how he has tackled the challenges of launching the first oral TRT softgel approved by the FDA.

Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces.

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

A repurposed drug could help improve immunotherapy response rates.

How can artificial intelligence and deep-learning platforms be used to combat malaria?

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.

Can we reverse the effect of the ageing process on the immune system?